Patent application number | Description | Published |
20100003267 | ANTI-ANGIOGENIC COMPOUNDS - The present invention provides VEGF binding peptides. In addition, the invention provides VEGF peptides conjugated to antibodies alone and in conjunction with other anti-angiogenic molecules. Various uses of the peptides and compounds are provided, including methods to treat disorders associated with abnormal angiogenesis. | 01-07-2010 |
20120201809 | MULTIFUNCTIONAL ANTIBODY CONJUGATES - The present invention relates to Multifunctional Antibody Conjugates, comprising an antibody or antigen binding portion thereof, comprising at least a fragment of a light chain constant kappa region (CLκ) comprising K | 08-09-2012 |
20120321591 | ANTI-ANGIOGENIC COMPOUNDS - The present invention provides various uses of VEGF binding peptides, including methods to treat disorders associated with abnormal angiogenesis. In addition, the invention provides VEGF peptides conjugated to antibodies alone and in conjunction with other anti-angiogenic molecules | 12-20-2012 |
20130323234 | MUTANT ANTIBODIES AND CONJUGATION THEREOF - The present invention relates to a polypeptide comprising 7 β-strands A, B, C, D, E, F, and G sequentially connected together by connecting chains of amino acids, and a first α-helix sequentially located on the EF chain between β-strands E and F, wherein the β-strands are arranged so as to form a first β-sheet comprising β-strands A, B, D, and E, and a second β-sheet comprising β-strands C, F and G, said first and second β-sheets being covalently bonded together so as to form a first Ig domain; wherein the EF chain between β-strands E and F comprises the sequence X | 12-05-2013 |
20150057431 | COMPOSITIONS FOR TREATING A DISEASE OR CONDITION ASSOCIATED WITH ABNORMAL ANGIOGENESIS - The present invention provides methods of treating (including preventing) a disease or condition associated with abnormal angiogenesis in a subject include administering a therapeutically effective amount of an AA targeting compound of the invention to the subject. The AA targeting compounds comprise AA targeting agent-linker conjugates which are linked to a combining site of an antibody. | 02-26-2015 |
Patent application number | Description | Published |
20120270928 | MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY - Described herein are compositions and methods for the inhibition of miR-21 activity. The compositions have certain nucleoside modification patterns that yield potent inhibitors of miR-21 activity. The compositions may be used to inhibit miR-21, and also to treat diseases associated with abnormal expression of miR-21, such as fibrosis and cancer. | 10-25-2012 |
20130123329 | MICRORNA COMPOSITIONS AND METHODS - Provided herein are compositions comprising oligomeric compounds. In certain embodiments, the oligomeric compounds are useful as miRNA mimics. The oligomeric compounds may mimic the activity of miR-34. Also provided herein are methods for the treatment of cancer. | 05-16-2013 |
20130289093 | MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY - Described herein are compositions and methods for the inhibition of miR-21 activity. The compositions have certain nucleoside modification patterns that yield potent inhibitors of miR-21 activity. The compositions may be used to inhibit miR-21, and also to treat diseases associated with abnormal expression of miR-21, such as fibrosis and cancer. | 10-31-2013 |
20140100263 | METHODS FOR TREATMENT OF ALPORT SYNDROME - Provided herein are methods for the treatment of Alport Syndrome, using modified oligonucleotides targeted to miR-21. In certain embodiments, a modified oligonucleotide targeted to miR-21 improves kidney function and/or reduces fibrosis in subjects having Alport Syndrome. In certain embodiments, administration of a modified oligonucleotide targeted to miR-21 delays the onset of end-stage renal disease in a subject having Alport Syndrome. In certain embodiments, a modified oligonucleotide targeted to miR-21 delays the need for dialysis or kidney transplant in a subject having Alport Syndrome. | 04-10-2014 |
20140107183 | MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY - Described herein are compositions and methods for the inhibition of miR-21 activity. The compositions have certain nucleoside modification patterns that yield potent inhibitors of miR-21 activity. The compositions may be used to inhibit miR-21, and also to treat diseases associated with abnormal expression of miR-21, such as fibrosis and cancer. | 04-17-2014 |
20140329887 | MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY - Described herein are compositions and methods for the inhibition of miR-21 activity. The compositions have certain nucleoside modification patterns that yield potent inhibitors of miR-21 activity. The compositions may be used to inhibit miR-21, and also to treat diseases associated with abnormal expression of miR-21, such as fibrosis and cancer. | 11-06-2014 |
20140350090 | MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-122 - Described herein are compositions and methods for the inhibition of miR-122 activity. The compositions have certain nucleoside modifications that yield potent inhibitors of miR-122 activity. The compounds may comprise conjugates to facilitate delivery to the liver. The compositions may be administered to subjects infected with hepatitis C virus, as a treatment for hepatitis C virus and related conditions. | 11-27-2014 |
20150031130 | COMPOUNDS AND METHODS FOR ENHANCED CELLULAR UPTAKE - Described herein are conjugated modified oligonucleotides that are complementary to a target RNA. The conjugate facilitates cellular uptake of the modified oligonucleotide, resulting improved potency. | 01-29-2015 |
20150087607 | MICRORNA COMPOSITIONS AND METHODS - Provided herein are compositions comprising oligomeric compounds. In certain embodiments, the oligomeric compounds are useful as miRNA mimics. The oligomeric compounds may mimic the activity of miR-34. Also provided herein are methods for the treatment of cancer. | 03-26-2015 |
20150105449 | MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-122 - Described herein are compositions and methods for the inhibition of miR-122 activity. The compositions have certain nucleoside modifications that yield potent inhibitors of miR-122 activity. The compounds may comprise conjugates to facilitate delivery to the liver. The compositions may be administered to subjects infected with hepatitis C virus, as a treatment for hepatitis C virus and related conditions. | 04-16-2015 |
20150218558 | MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY - Described herein are compositions and methods for the inhibition of miR-21 activity. The compositions have certain nucleoside modification patterns that yield potent inhibitors of miR-21 activity. The compositions may be used to inhibit miR-21, and also to treat diseases associated with abnormal expression of miR-21, such as fibrosis and cancer. | 08-06-2015 |
20150299704 | METHODS FOR TREATMENT OF ALPORT SYNDROME - Provided herein are methods for the treatment of Alport Syndrome, using modified oligonucleotides targeted to miR-21. In certain embodiments, a modified oligonucleotide targeted to miR-21 improves kidney function and/or reduces fibrosis in subjects having Alport Syndrome. In certain embodiments, administration of a modified oligonucleotide targeted to miR-21 delays the onset of end-stage renal disease in a subject having Alport Syndrome. In certain embodiments, a modified oligonucleotide targeted to miR-21 delays the need for dialysis or kidney transplant in a subject having Alport Syndrome. | 10-22-2015 |
20160138016 | MICRORNA COMPOUNDS AND METHODS FOR MODULATING MIR-21 ACTIVITY - Described herein are compositions and methods for the inhibition of miR-21 activity. The compositions have certain nucleoside modification patterns that yield potent inhibitors of miR-21 activity. The compositions may be used to inhibit miR-21, and also to treat diseases associated with abnormal expression of miR-21, such as fibrosis and cancer. | 05-19-2016 |
Patent application number | Description | Published |
20130009179 | COMPACT OPTICALLY EFFICIENT SOLID STATE LIGHT SOURCE WITH INTEGRATED THERMAL MANAGEMENT - A compact and efficient LED array lighting component comprising a circuit board with an array of LED chips mounted on it and electrically interconnected. A plurality of primary lenses is included, each of which is formed directly over each LED chip and/or a sub-group of the LED chips. A heat sink is included with the circuit board mounted to the heat sink so that heat from the LED chips spreads into the heat sink. In some embodiments the circuit board can be thermally conductive and electrically insulating. Method of forming an LED component are also disclosed utilizing chip-on-board mounting techniques for mounting the LED chips on the circuit board, and molding of the primary lenses directly over the LED chips individually or in sub-groups of LED chips. | 01-10-2013 |
20150200335 | WAFER LEVEL CONTACT PAD SOLDER BUMPING FOR SURFACE MOUNT DEVICES WITH NON-PLANAR RECESSED CONTACTING SURFACES - This disclosure related to surface mount devices, such as light emitting devices, and methods of manufacture thereof, including recessed contact pads with protruding contact bumps. Embodiments according to the present disclosure include a light emitting device, wherein the device comprises at least a contact pad, such that the contact pad is recessed in relation to a surface of the device. Contact bumps are formed in contact with the contact pads, such that the contact bumps protrude beyond the surface and may contact a surface of a submount that the device is meant to be mounted to. Methods of manufacture including methods utilizing virtual wafer structures are also disclosed. | 07-16-2015 |
20150325759 | OPTICAL ELEMENT WITH INTEGRATED INDICATOR - Solid state fixtures and packages are disclosed that include an optical element, such as an encapsulant, having an integrated indicator which indicates one or more characteristics of the package to a user, such as package orientation, polarity, chip-type, etc. The host optical element can be substantially symmetrical but for the indicator. Indicators can be additive, such as a bump, or subtractive, such as a hole. The indicator can be visible to the human eye, and/or can be machine detectable, such as by pick-and-place technology. Indicators can be formed by many processes including molding and laser ablation/imprinting, which is particularly suited for use with a hard host material. | 11-12-2015 |
20160072022 | LED PACKAGES WITH CHIPS HAVING INSULATED SURFACES - Emitter packages are disclosed that can include an insulating layer covering the emitter, such as between the emitter's primary emission surface and a lens or encapsulant. The packages can comprise a submount with an emitter flip-chip mounted such that the diode region is between the emitter's non-insulating and/or conductive substrate and the submount. The submount can then be covered with a thin insulating layer. The same or another insulating layer can cover other electrically active surfaces on the submount. By insulating the electrically active surfaces of the emitter and, in some embodiments, other electrically active surfaces, the package can meet UL8750 class 4 enclosure standards even if it does not meet the lens adhesion criteria. This can enable the use of cheaper and/or more optically efficient materials at the fixture level, since the package itself meets class 4 standards. | 03-10-2016 |
Patent application number | Description | Published |
20100142527 | Scalable IP-Services Enabled Multicast Forwarding with Efficient Resource Utilization - Methods and apparatus are provided for managing multicast Internet Protocol (IP) flows. According to one embodiment, a multicast IP flow is identified at an interface of a network device using information from a packet header. For any newly identified multicast IP flow, if flow-specific services are required, a new first transmit control block (TCB), which includes one or more attributes relating to flow-specific services required by the newly identified multicast IP flow, is created for the newly identified multicast IP flow. Otherwise, if flow-specific services are not required by the newly identified multicast IP flow, a default second TCB, which excludes any attributes relating to flow-specific services and which includes one or more attributes related to a virtual interface (VI) serving as an outbound interface (OIF) for the newly identified multicast IP flow, is used. | 06-10-2010 |
20110122872 | SCALABLE IP-SERVICES ENABLED MULTICAST FORWARDING WITH EFFICIENT RESOURCE UTILIZATION - Methods, apparatus and data structures are provided for managing multicast IP flows. According to one embodiment, a network switch module includes a memory and multiple processors partitioned among multiple virtual routers (VRs). Each VR maintains a data structure including information relating to multicast sessions handled by the VR and including a first pointer for each multicast session, a chain of blocks of second pointers and one or more TCBs. Each first pointer points to a chain of blocks of second pointers. Each second pointer corresponds to an OIF of the VR participating in the multicast session defined by the first pointer and defines how many times to replicate packets associated with the multicast session. The TCBs store control information relevant to processing or routing packets. Each second pointer points to a TCB, which identifies the OIF out which packets of the multicast session are transmitted from the VR. | 05-26-2011 |
20130156033 | SCALABLE IP-SERVICES ENABLED MULTICAST FORWARDING WITH EFFICIENT RESOURCE UTILIZATION - Methods, apparatus and data structures are provided for managing multicast IP flows. According to one embodiment, active multicast IP sessions are identified by a router. A data structure is maintained by the router and contains therein information regarding the multicast sessions, including a first pointer for each of the multicast sessions, at least one chain of one or more blocks of second pointers and one or more transmit control blocks (TCBs). Each first pointer points to a chain of one or more blocks of second pointers. Each second pointer corresponds to an outbound interface (OIF) participating in the multicast session and identifies a number of times packets associated with the multicast session are to be replicated. The TCBs have stored therein control information to process or route packets. Each second pointer points to a TCB that identifies an OIF of the router through which packets are to be transmitted. | 06-20-2013 |
20140245076 | SYSTEM AND METHOD FOR PRESERVING CRITICAL DEBUG DATA IN A PORTABLE COMPUTING DEVICE - One or more triggers may be coupled to sources on a system on a chip of a portable computing device. The sources monitor the system for status conditions. The one or more triggers are coupled to a trigger bus. A sequencer engine is coupled to the trigger bus and a communication bus. The sequencer engine receives one or more instructions from the communication bus for determining how the sequencer engine should monitor the one or more triggers via the trigger bus and preserve data received from the one or more triggers before a system reset. The sequencer engine then receives data from the one or more triggers and stores the data in local memory storage. The sequencer engine, if programmed, may generate at least one of a trace packet, an interrupt signal, and a general purpose input/output signal in response to receiving data from one or more triggers. | 08-28-2014 |
20150079909 | DYNAMIC FREQUENCY PLAN - In one configuration, an apparatus and a method to operate the apparatus are provided. The apparatus includes at least one processor configured to receive operating information indicating a set of operating frequencies from a first circuit and to select an operating frequency from the set of operating frequencies. The at least one processor is further arranged to configure an operation of a second circuit based on the selected operating frequency. In another configuration, the apparatus includes at least one processor configured to select a set of operating frequencies based a radio frequency operation and to transmit operating information indicating the set of operating frequencies to a control circuit. | 03-19-2015 |
20150156234 | SCALABLE IP-SERVICES ENABLED MULTICAST FORWARDING WITH EFFICIENT RESOURCE UTILIZATION - Methods, apparatus and data structures are provided for managing multicast IP flows. According to one embodiment, active multicast IP sessions are identified by a network device. A data structure is maintained by the network device and contains therein information regarding the multicast sessions, including a first value for each of the multicast sessions, at least one chain of one or more blocks of second values and one or more transmit control blocks (TCBs). Each first value is indicative of a chain of one or more blocks of second values. Each second value corresponds to an outbound interface (OIF) participating in the multicast session and identifies a number of times packets associated with the multicast session are to be replicated. The TCBs have stored therein control information to process or route packets. Each second value is indicative of a TCB that identifies an OIF of the network device through which packets are to be transmitted. | 06-04-2015 |
20150280929 | SCALABLE IP-SERVICES ENABLED MULTICAST FORWARDING WITH EFFICIENT RESOURCE UTILIZATION - Methods, apparatus and data structures are provided for managing multicast IP flows. According to one embodiment, a network switch module includes a memory and multiple processors partitioned among multiple virtual routers (VRs). Each VR maintains a data structure containing therein information regarding the multicast sessions, including a first value for each of the multicast sessions, at least one chain of one or more blocks of second values and one or more transmit control blocks (TCBs). Each first value is indicative of a chain of one or more blocks of second values. Each second value corresponds to an outbound interface (OIF) participating in the multicast session and identifies a number of times packets associated with the multicast session are to be replicated. The TCBs have stored therein control information to process or route packets. Each second value is indicative of a TCB that identifies an OIF of the network device through which packets are to be transmitted. | 10-01-2015 |
Patent application number | Description | Published |
20100322849 | ENHANCED B CELL CYTOTOXICITY OF CDIM BINDING ANTIBODY - Formulations and methods of treating human patients suffering from a condition characterized by lymphoid cancer, autoimmune disease or B cell hyperproliferation are disclosed, the treatment comprising administering (1) a cytotoxic amount of an antibody having specific binding for CDIM epitopes on a B cell, and (2) a cytotoxic agent, including a chemotherapeutic agent, radioactive isotope, cytotoxic antibody, immunoconjugate, ligand conjugate, immunosuppressant, cell growth regulator and/or inhibitor, toxin, or mixtures thereof, including agents that disrupt the cytoskeleton of B cells, particularly vinca alkaloids or colchicine. | 12-23-2010 |
20120237441 | ENHANCED B CELL CYTOTOXICITY OF CDIM BINDING ANTIBODY - Formulations and methods of treating human patients suffering from a condition characterized by lymphoid cancer, autoimmune disease or B cell hyperproliferation are disclosed, the treatment comprising administering (1) a cytotoxic amount of an antibody having specific binding for CDIM epitopes on a B cell, and (2) a cytotoxic agent, including a chemotherapeutic agent, radioactive isotope, cytotoxic antibody, immunoconjugate, ligand conjugate, immunosuppressant, cell growth regulator and/or inhibitor, toxin, or mixtures thereof, including agents that disrupt the cytoskeleton of B cells, particularly vinca alkaloids or colchicine. | 09-20-2012 |
20130164283 | Antibody induced cell membrane wounding - Compositions and methods for inducing cell membrane wounding, cell permeabilization and cell killing are provided. The composition comprises a polyvalent agent that binds to a highly expressed cell surface antigen present on the surface of a cell. Preferably, the cell surface antigen is associated with the cytoskeleton of the cell. A preferred polyvalent agent is an IgM, and enhanced cell wounding and killing can be provided by the addition of a crosslinking agent. At sublethal concentrations in vivo, the cell wounding antibodies permeabilize cells and dramatically enhance response to chemotherapeutic agents, even in patients refractory to the chemotherapeutic agents. | 06-27-2013 |
20140044739 | CDIM Binding Proteins And Uses Thereof - The present disclosure relates to Cell Death Inducing Molecule (“CDIM”) binding proteins and pharmaceutical compositions thereof. Particularly, the disclosure provides CDIM binding proteins that are useful in the selective depleting and killing of B cells, including neoplastic B cells as well as neoplastic cells that are not of B-cell origin that express CDIM-like antigens. In addition, the disclosure encompasses polynucleotides encoding the disclosed antigen binding proteins, and expression systems for producing the same. Further the present disclosure encompasses methods of treating patients with B cell proliferative- and mediated diseases by administering the CDIM binding proteins as well as diagnostic assays for identifying proteins that bind to CDIM. The disclosure further contemplates diagnostic assays for identifying patient populations that can be treated with the CDIM binding proteins. | 02-13-2014 |
Patent application number | Description | Published |
20100244457 | ENERGY HARVESTING SYSTEM - Energy harvesting systems are described in which electroactive materials, such as dielectric elastomers, may be utilized to absorb the shocks, bumps, and vibrations from the road or path to generate energy which is captured and stored for use in the vehicle to provide additional power for any number of uses. Other devices and systems, such as household appliances which dissipate vibrational energy, may also incorporate any number of the dielectric elastomer generators. | 09-30-2010 |
20110032103 | MOTION DETECTION SYSTEM - A motion detection system for detecting movement and/or breathing from a subject, e.g., for preventing SIDS, can incorporate a sensor in communication with a fluid-filled chamber while optionally combining audio and/or video monitoring systems. The sensor module may have a housing which can be attached, e.g., to an article of clothing worn by the subject. The sensor may be entirely enclosed within the housing which may also be filled with a vibrationally transmissive medium which transmits movements from the subject such that these signals impinge upon the sensor which captures these signals (or the absence of these signals) for processing and possibly alerting a parent or caretaker. | 02-10-2011 |
20110239372 | Personal support device that provides uniform distribution of pressure on a body portion - Embodiments of the technology provide a personal support device for provision of therapeutic support to a portion of a body resting thereon and methods associated with the device. Device embodiments include a substrate having an array of pressure-distributing element host sites, and a population of volumetrically-incompressible pressure-distributing elements at the host sites to form an array of pressure-distributing elements. A therapeutic surface overlays the pressure-distributing elements, and provides an interface between the array of pressure-distributing elements and an aspect of the body portion in contact with the therapeutic surface. The device is configured to form a supportive site within the therapeutic surface that is conformative to the aspect of the body portion in contact with the therapeutic surface when the body part is lying thereon. The supportive site is further configured to apply a substantially uniform distribution of pressure against the aspect of the body part in contact with the supportive site. | 10-06-2011 |
20130019873 | METHOD AND DEVICES FOR PREVENTION AND TREATMENT OF PRESSURE ULCERS - Method and devices for the prevention and treatment of pressure ulcers are described in which a portable support assembly may be worn by a bed-stricken individual around particular regions of the body where pressure ulcers tend to form. The portable support assembly may generally include one or more individual fluid filled pods which are enclosed entirely within an inner fluid pad localized along a central portion. Both the one or more pods and inner fluid pad are then enclosed entirely by another layer of fluid within an outer fluid pad which extends over the entire assembly. Each of the fluid layers may be secured to an outer shell which is relatively stiffer than the fluid layers and may restrict or limit the expansion or movement of the fluid pods and/or fluid pads. | 01-24-2013 |
20130019881 | SYSTEM FOR PREVENTION AND TREATMENT OF PRESSURE ULCERS - System for the prevention and treatment of pressure ulcers arc described in which a portable support assembly may be worn by a bed-stricken individual around particular regions of the body where pressure ulcers tend to form. The portable support assembly may generally include one or more individual spring assemblies which are enclosed entirely within an inner fluid and/or outer fluid pad which extends over the entire assembly. Each of the spring assemblies may be secured to an outer shell which is relatively stiffer than the fluid layers. | 01-24-2013 |
20130092175 | APPARATUS AND METHODS FOR ADJUSTING A SUPPORT TO A BODY - Apparatus and methods for adjusting a support to a body are described in which a portable support assembly may be worn by a bed-stricken individual around particular regions of the body where pressure ulcers tend to form. The portable support assembly may generally include adjustable supports which conform the assembly to the patient's body and which also help to distribute one or more fluid pad assemblies relative to the body. | 04-18-2013 |
20130104796 | SWALLOWING INDICATOR FOR SOLID OBJECTS | 05-02-2013 |
20130112213 | APPARATUS AND METHODS FOR CONFORMING A SUPPORT TO A BODY - Apparatus and methods for conforming a support to a body are described in which a portable support assembly may be worn by a bed-stricken individual around particular regions of the body where pressure ulcers tend to form. The portable support assembly may generally include adjustable supports which conform the assembly to the patient's body and which also help to distribute one or more fluid pad assemblies relative to the body. | 05-09-2013 |
20130161957 | ENERGY GENERATING SUPPORTS - Energy harvesting systems are described in which electroactive materials, such as dielectric elastomers, may be utilized to absorb the shocks, bumps, and vibrations from the road or path to generate energy which is captured and stored for use in the vehicle to provide additional power for any number of uses. Other devices and systems. such as household appliances which dissipate vibrational energy, may also incorporate any number of the dielectric elastomer generators. | 06-27-2013 |
20130174855 | METHOD AND DEVICES FOR PREVENTION AND TREATMENT OF PRESSURE ULCERS - Method and devices for the prevention and treatment of pressure ulcers are described in which a portable support assembly may be worn by a bed-stricken individual around particular regions of the body where pressure ulcers tend to form. The portable support assembly may generally include one or more individual fluid filled pods which are enclosed entirely within an inner fluid pad localized along a central portion. Both the one or more pods and inner fluid pad are then enclosed entirely by another layer of fluid within an outer fluid pad which extends over the entire assembly. Each of the fluid lavers may be secured to an outer shell which is relatively stiffer than the fluid layers and may restrict or limit the expansion or movement of the fluid pods and/or fluid pads. | 07-11-2013 |
20130174856 | METHOD AND DEVICES FOR PREVENTION AND TREATMENT OF PRESSURE ULCERS - Method and devices for the prevention and treatment of pressure ulcers are described in which a portable support assembly may be worn by a bed-stricken individual around particular regions of the body where pressure ulcers tend to form. The portable support assembly may generally include one or more individual fluid filled pods which are enclosed entirely within an inner fluid pad localized along, a central portion. Both the one or more pods and inner fluid pad are then enclosed entirely by another layer of fluid within an outer fluid pad which extends over the entire assembly. Each of the fluid lavers may be secured to an outer shell which is relatively stiffer than the fluid layers and may restrict or limit the expansion or movement of the fluid pods and/or fluid pads. | 07-11-2013 |
20130174859 | APPARATUS AND METHODS FOR CONFORMING A SUPPORT TO A BODY - Apparatus and methods for conforming a support to a body are described in which a portable support assembly may be worn by a bed-stricken individual around particular regions of the body where pressure ulcers tend to form. The portable support assembly may generally include adjustable supports which conform the assembly to the patient's body and which also help to distribute one or more fluid pad assemblies relative to the body. | 07-11-2013 |
20130180530 | ADJUSTABLE SUPPORT SYSTEM - Apparatus and methods for adjusting a support to a body are described in which a portable support assembly may be worn or used by a bed-stricken or wheel-chair restricted individual around particular regions of the body where pressure ulcers tend to form. The portable support assembly may generally include adjustable supports which conform the assembly to the patient's body and which also help to distribute one or more fluid pad assemblies relative to the body. The support assembly may be incorporated into a design for a wheelchair or a bed. | 07-18-2013 |
20130180531 | INDEPENDENTLY ADJUSTABLE SUPPORT SYSTEM - Apparatus and methods for adjusting a support to a body are described in which a portable support assembly may be worn or used by a bed-stricken or wheel-chair restricted individual around particular regions of the body where pressure ulcers tend to form. The portable support assembly may generally include adjustable supports which conform the assembly to the patient's body and which also help to distribute one or more fluid pad assemblies relative to the body. The support assembly may be incorporated into a design for a wheelchair or a bed. | 07-18-2013 |
20130190678 | PERSONALIZABLE SYSTEM AND METHOD FOR ANESTHETIZING THE TYMPANIC MEMBRANE - Systems and methods are provided for anesthetizing a tympanic membrane of an ear. The systems are personalizable to ensure proper anesthetizing solution administration. The systems and methods may also be useful for administering a solution to the ear canal of a human patient and for maintaining the solution therein. | 07-25-2013 |
20130298918 | INDEPENDENTLY ADJUSTABLE SUPPORT SYSTEM - Apparatus and methods for adjusting a support to a body are described in which a portable support assembly may be worn or used by a bed-stricken or wheel-chair restricted individual around particular regions of the body where pressure ulcers tend to form. The portable support assembly may generally include adjustable supports which conform the assembly to the patient's body and which also help to distribute one or more fluid pad assemblies relative to the body. The support assembly may be incorporated into a design for a wheelchair or a bed. | 11-14-2013 |
20140102461 | Adhesive Earplugs Useful for Sealing the Ear Canal - Systems and methods are provided for sealing an ear canal for retaining a solution in the ear canal. Adhesive earplugs are provided through which the solution can be delivered, and which, following delivery, retain the fluid in the ear canal. The systems and methods may also be useful for delivering an anesthetizing solution to the ear canal of a human patient and for maintaining the solution therein for use with an iontophoresis system for anesthetizing the tympanic membrane. | 04-17-2014 |
20140249382 | MOTION DETECTION SYSTEM - A motion detection system for detecting movement and/or breathing from a subject, e.g., for preventing SIDS, can incorporate a sensor in communication with a fluid-filled chamber while optionally combining audio and/or video monitoring systems. The sensor module may have a housing which can be attached, e.g., to an article of clothing worn by the subject. The sensor may be entirely enclosed within the housing which may also be filled with a vibrationally transmissive medium which transmits movements from the subject such that these signals impinge upon the sensor which captures these signals (or the absence of these signals) for processing and possibly alerting a parent or caretaker. | 09-04-2014 |
20150052685 | CONFORMABLE SUPPORT SYSTEM - Conformable support systems for conforming to a body are described in which a support assembly may be provided to support particular regions of the body where pressure ulcers tend to form. The conforming support may generally comprise a central portion, a first side portion attached to the central portion, and a second side portion attached to the central portion opposite to the first side portion. Each of the chambers are in fluid communication with one another such that a pressure applied upon the central chamber reconfigures the support assembly from a flattened configuration to an angled configuration in which fluid or gas within the central portion is urged into the first and/or second portions such that the side portions pivot to a predetermined height and angle relative to the central portion and form a conforming channel sized to support a region of a patient body | 02-26-2015 |
20150196776 | DISINFECTION USING LIGHT THERAPY - Disinfection using light therapy is described herein where a support platform which is configured to support a region of a patient's body may integrate or incorporate one or more light elements positioned within, upon, or in proximity to the support platform for exposing the patient's body to the light therapy. Additionally, light sources and/or heating elements may also be incorporated with mattresses and/or covers for disinfection prior to patient use. | 07-16-2015 |
20150238378 | MULTI-LAYERED CUSHIONING SUPPORT - Multi-layer cushion supports are described which may generally comprise a first support having a first contact surface for contacting a portion of a body and a second surface opposite to the first surface, the first support defining a central chamber and a peripheral chamber surrounding the central chamber, wherein the first support is filled with a first gas or liquid and a second support attached to the first support along the first contact surface. The second support may be filled with a second gas or liquid which is relatively more viscous than the first gas or liquid. In particular, the first support may be filled with a volume of air and the second support may be filled with oil which is less than the volume of air. | 08-27-2015 |
20160128623 | CUSHIONING SUPPORT FOR MONITORING USER ACTIVITY - Multi-layer cushion supports are described which may generally comprise a first support having a first contact surface for contacting a portion of a body and a second surface opposite to the first surface, the first support defining a central chamber and a peripheral chamber surrounding the central chamber, wherein the first support is filled with a first gas or liquid and a second support attached to the first support along the first contact surface. The second support may be filled with a second gas or liquid which is relatively more viscous than the first gas or liquid. In particular, the first support may be filled with a volume of air and the second support may be filled with oil which is less than the volume of air. | 05-12-2016 |
Patent application number | Description | Published |
20110074911 | Gesture-Based Actions in a Video Communication Session - In one embodiment, a method for transferring a communication session detects a transfer indication generated by a user of a first video conference system, where the transfer indication requests to transfer an active voice communication session. The method acquires image information associated with the transfer indication, where the image information includes at least one frame captured from a second video conference system having an active video conference session with the first video conference system. The method identifies a mobile communication device associated with the transfer indication and having the active voice communication session and identifies a target communication device using the image information associated with the transfer indication. The method also initiates transfer of the voice communication session to the target communication device. | 03-31-2011 |
20110091030 | DYNAMIC CALLBACKS FROM A CONTACT CENTER - A contact center is provided. The contract center may include an input and a processor. The input is operable to receive communication from a first contact media type. The processor is operable to respond to communication from the first contact media type by initiating communication with a second contact media type, the first and second contact media types being associated with a contact and the first contact media type being different from the second contact media type. | 04-21-2011 |
20110191134 | CONTACT OFFER TIME FOR AGENTS SUPPORTING CONTACT CENTERS - A method for assisting an agent supporting a contact center is provided. The method includes obtaining one or more contact offer factors, determining a contact offer time for the agent supporting the contact center based on the one or more contact offer factors, and providing the contact offer time to the agent. The contact offer time defines when the agent will receive a contact offer. | 08-04-2011 |
20120210247 | INTELLIGENT SOCIAL COLLABORATION UNIFIED MEDIA - In one embodiment, a method includes receiving information from a user in a collaboration network, the information including a unit of content, a title, an indication of one or more entities in the collaboration network allowed to access the unit of content, and for each of the entities in the collaboration network allowed to access the unit of content, an indication of a permission level with respect to the access. The permission level includes view, comment, edit, or share. The method further includes determining a format for presentation of the unit of content based at least in part on the permission levels indicated for the one or more entities in the collaboration network allowed to access the unit of content, and publishing the unit of content and the title for the unit of content to the collaboration network in the determined format and according to the information. | 08-16-2012 |
20130063542 | SYSTEM AND METHOD FOR CONFIGURING VIDEO DATA - A method is provided in one example implementation and includes receiving video data associated with a plurality of video streams during a communication session; receiving a rule selection for a particular video stream that is selected from the plurality of video streams; and displaying the particular video stream based on the rule selection. In more specific examples, the rule selection includes a designation for a video stream corresponding to an active speaker in the communication session, or a designation for a video stream associated with speech that is spoken prior to the active speaker in the communication session, or a designation for a video stream associated with a particular word recited in the communication session, or a designation for a video stream associated with a profile, which identifies an expertise of a participant of the communication session. | 03-14-2013 |
20130297689 | Activity Stream Tuning Using Multichannel Communication Analysis - A social graph is constructed to be representative of a social network by including nodes and edges representing activities in the social network. Activities in communication transactions of a communication network are identified and activity stream tuning parameters are determined for a user of the social network from the identified relationships. Activity stream data is presented to the user in accordance with the tuning parameters. | 11-07-2013 |
20140118472 | Active Speaker Indicator for Conference Participants - In one embodiment, a method includes receiving requests to join a conference from a plurality of user devices proximate a first endpoint. The requests include a username. The method also includes receiving an audio signal for the conference from the first endpoint. The first endpoint is operable to capture audio proximate the first endpoint. The method also includes transmitting the audio signal to a second endpoint, remote from the first endpoint. The method also includes identifying, by a processor, an active speaker proximate the first endpoint based on information received from the plurality of user devices. | 05-01-2014 |
20140237041 | AUTOMATIC FUTURE MEETING SCHEDULER BASED UPON LOCATIONS OF MEETING PARTICIPANTS - In a network that supports communications between client devices and at least one meeting server, a meeting request that includes one or more meeting constraints to be satisfied is monitored prior to scheduling or initiating a meeting between a plurality of meeting participants associated with respective client devices. At least one meeting constraint includes a location constraint that identifies a location for a client device associated with a meeting participant prior to scheduling or initiating the meeting. In response to each meeting constraint being satisfied, including the at least one location constraint, the meeting is automatically scheduled or initiated for the participants via the meeting server. | 08-21-2014 |
Patent application number | Description | Published |
20130054888 | CONFIGURING OBJECT STORAGE SYSTEM FOR INPUT/OUTPUT OPERATIONS - The storage system exports logical storage volumes that are provisioned as storage objects. These storage objects are accessed on demand by connected computer systems using standard protocols, such as SCSI and NFS, through logical endpoints for the protocol traffic that are configured in the storage system. When an input-output command (IO) is received at the storage system, an identifier is retrieved from the IO and translated into a logical storage volume identifier, and the IO is executed on storage locations referenced by a logical storage volume corresponding to the logical storage volume identifier. | 02-28-2013 |
20130054932 | OBJECT STORAGE SYSTEM - The storage system exports logical storage volumes that are provisioned as storage objects. These storage objects are accessed on demand by connected computer systems using standard protocols, such as SCSI and NFS, through logical endpoints for the protocol traffic that are configured in the storage system. Logical storage volumes are created from a logical storage container having an address space that maps to storage locations of the physical data storage units. Each of the logical storage volumes so created has an address space that maps to the address space of the logical storage container. A logical storage container may span more than one storage system and logical storage volumes of different customers can be provisioned from the same logical storage container with appropriate security settings. | 02-28-2013 |
20130055249 | VIRTUAL MACHINE PROVISIONING IN OBJECT STORAGE SYSTEM - The storage system exports logical storage volumes that are provisioned as storage objects. These storage objects are accessed on demand by connected computer systems using standard protocols, such as SCSI and NFS, through logical endpoints for the protocol traffic that are configured in the storage system. When a virtual machine is provisioned, logical storage volumes include a logical metadata storage volume and logical data storage volumes. The logical metadata storage volume stores metadata for the virtual machine such as configuration and log files, swap file, and disk descriptor files. Each disk descriptor file is provided for one logical data storage volume and stores metadata about the logical data storage volume such as size and unique identifying data. | 02-28-2013 |
20130212577 | APPLICATION-SPECIFIC DATA IN-FLIGHT SERVICES - Embodiments provide data in-flight services (DIFS) to software applications such as virtual machines (VMs) at an application level without requiring modification to established storage protocols. In exemplary embodiments, a software application is associated with a DIFS policy indicating one or more DIFS services to apply to the software application. Data transmitted by the software application to a destination is tagged based on the DIFS policy associated with the software application and transmitted to the destination. | 08-15-2013 |
20140181398 | Configuring Object Storage System for Input/Output Operations - A method processes input-output commands (IOs) in a storage system. The storage system receives an IO including first and second identifiers. The first identifier is used to direct the IO to the storage system. At the storage system, the method retrieves the second identifier from the IO and translates the second identifier to a logical storage volume identifier. Then, the method executes the IO on storage locations referenced by a logical storage volume corresponding to the logical storage volume identifier. | 06-26-2014 |
20140244929 | OBJECT STORAGE SYSTEM - The storage system exports logical storage volumes that are provisioned as storage objects. These storage objects are accessed on demand by connected computer systems using standard protocols, such as SCSI and NFS, through logical endpoints for the protocol traffic that are configured in the storage system. Logical storage volumes are created from a logical storage container having an address space that maps to storage locations of the physical data storage units. Each of the logical storage volumes so created has an address space that maps to the address space of the logical storage container. A logical storage container may span more than one storage system and logical storage volumes of different customers can be provisioned from the same logical storage container with appropriate security settings. | 08-28-2014 |
20150106815 | APPLICATION-SPECIFIC DATA IN-FLIGHT SERVICES ALONG A COMMUNICATION PATH SELECTED BASED ON A DIF SERVICES POLICY ASSOCIATED WITH A VM - Embodiments provide data in-flight (DIF) services to software applications such as virtual machines (VMs) at an application level without requiring modification to established storage protocols. In exemplary embodiments, a software application is associated with a DIF services policy indicating one or more DIF services to apply to the software application. Data transmitted by the software application to a destination is tagged based on the DIF services policy associated with the software application and transmitted to the destination. | 04-16-2015 |
Patent application number | Description | Published |
20120277452 | Tailored Oils Produced From Recombinant Oleaginous Microorganisms - Methods and compositions for the production of oil, fuels, oleochemicals, and other compounds in recombinant microorganisms are provided, including oil-bearing microorganisms and methods of low cost cultivation of such microorganisms. Microalgal cells containing exogenous genes encoding, for example, a lipase, a sucrose transporter, a sucrose invertase, a fructokinase, a polysaccharide-degrading enzyme, a keto acyl-ACP synthase enzyme, a fatty acyl-ACP thioesterase, a fatty acyl-CoA/aldehyde reductase, a fatty acyl-CoA reductase, a fatty aldehyde reductase, a fatty acid hydroxylase, a desaturase enzyme, a fatty aldehyde decarbonylase, and/or an acyl carrier protein are useful in manufacturing transportation fuels such as renewable diesel, biodiesel, and renewable jet fuel, as well as oleochemicals such as functional fluids, surfactants, soaps and lubricants. | 11-01-2012 |
20130034887 | Tailored Oils Produced from Recombinant Oleaginous Microorganisms - Methods and compositions for the production of oil, fuels, oleochemicals, and other compounds in recombinant microorganisms are provided, including oil-bearing microorganisms and methods of low cost cultivation of such microorganisms. Microalgal cells containing exogenous genes encoding, for example, a lipase, a sucrose transporter, a sucrose invertase, a fructokinase, a polysaccharide-degrading enzyme, a keto acyl-ACP synthase enzyme, a fatty acyl-ACP thioesterase, a fatty acyl-CoA/aldehyde reductase, a fatty acyl-CoA reductase, a fatty aldehyde reductase, a fatty acid hydroxylase, a desaturase enzyme, a fatty aldehyde decarbonylase, and/or an acyl carrier protein are useful in manufacturing transportation fuels such as renewable diesel, biodiesel, and renewable jet fuel, as well as oleochemicals such as functional fluids, surfactants, soaps and lubricants. | 02-07-2013 |
20130197247 | GENETICALLY ENGINEERED MICROBIAL STRAINS INCLUDING PROTOTHECA LIPID PATHWAY GENES - Genetically engineered microbial, e.g., | 08-01-2013 |
20130316410 | Tailored Oils - Recombinant DNA techniques are used to produce oleaginous recombinant cells that produce triglyceride oils having desired fatty acid profiles and regiospecific or stereospecific profiles. Genes manipulated include those encoding stearoyl-ACP desturase, delta 12 fatty acid desaturase, acyl-ACP thioesterase, ketoacyl-ACP synthase, and lysophosphatidic acid acyltransferase. The oil produced can have enhanced oxidative or thermal stability, or can be useful as a frying oil, shortening, roll-in shortening, tempering fat, cocoa butter replacement, as a lubricant, or as a feedstock for various chemical processes. The fatty acid profile can be enriched in midchain profiles or the oil can be enriched in triglycerides of the saturated-unsaturated-saturated type. | 11-28-2013 |
20130317240 | Tailored Oils - Recombinant DNA techniques are used to produce oleaginous recombinant cells that produce triglyceride oils having desired fatty acid profiles and regiospecific or stereospecific profiles. Genes manipulated include those encoding stearoyl-ACP desturase, delta 12 fatty acid desaturase, acyl-ACP thioesterase, ketoacyl-ACP synthase, and lysophosphatidic acid acyltransferase. The oil produced can have enhanced oxidative or thermal stability, or can be useful as a frying oil, shortening, roll-in shortening, tempering fat, cocoa butter replacement, as a lubricant, or as a feedstock for various chemical processes. The fatty acid profile can be enriched in midchain profiles or the oil can be enriched in triglycerides of the saturated-unsaturated-saturated type. | 11-28-2013 |
20130323382 | Tailored Oils - Recombinant DNA techniques are used to produce oleaginous recombinant cells that produce triglyceride oils having desired fatty acid profiles and regiospecific or stereospecific profiles. Genes manipulated include those encoding stearoyl-ACP desturase, delta 12 fatty acid desaturase, acyl-ACP thioesterase, ketoacyl-ACP synthase, and lysophosphatidic acid acyltransferase. The oil produced can have enhanced oxidative or thermal stability, or can be useful as a frying oil, shortening, roll-in shortening, tempering fat, cocoa butter replacement, as a lubricant, or as a feedstock for various chemical processes. The fatty acid profile can be enriched in midchain profiles or the oil can be enriched in triglycerides of the saturated-unsatturated-saturated type. | 12-05-2013 |
20130323823 | Tailored Oils - Recombinant DNA techniques are used to produce oleaginous recombinant cells that produce triglyceride oils having desired fatty acid profiles and regiospecific or stereospecific profiles. Genes manipulated include those encoding stearoyl-ACP desturase, delta 12 fatty acid desaturase, acyl-ACP thioesterase, ketoacyl-ACP synthase, and lysophosphatidic acid acyltransferase. The oil produced can have enhanced oxidative or thermal stability, or can be useful as a frying oil, shortening, roll-in shortening, tempering fat, cocoa butter replacement, as a lubricant, or as a feedstock for various chemical processes. The fatty acid profile can be enriched in midchain profiles or the oil can be enriched in triglycerides of the saturated-unsaturated-saturated type. | 12-05-2013 |
20130331584 | Tailored Oils - Recombinant DNA techniques are used to produce oleaginous recombinant cells that produce triglyceride oils having desired fatty acid profiles and regiospecific or stereospecific profiles. Genes manipulated include those encoding stearoyl-ACP desturase, delta 12 fatty acid desaturase, acyl-ACP thioesterase, ketoacyl-ACP synthase, and lysophosphatidic acid acyltransferase. The oil produced can have enhanced oxidative or thermal stability, or can be useful as a frying oil, shortening, roll-in shortening, tempering fat, cocoa butter replacement, as a lubricant, or as a feedstock for various chemical processes. The fatty acid profile can be enriched in midchain profiles or the oil can be enriched in triglycerides of the saturated-unsaturated-saturated type. | 12-12-2013 |
20130338385 | Tailored Oils - Recombinant DNA techniques are used to produce oleaginous recombinant cells that produce triglyceride oils having desired fatty acid profiles and regiospecific or stereospecific profiles. Genes manipulated include those encoding stearoyl-ACP desturase, delta 12 fatty acid desaturase, acyl-ACP thioesterase, ketoacyl-ACP synthase, and lysophosphatidic acid acyltransferase. The oil produced can have enhanced oxidative or thermal stability, can be useful as a frying oil, shortening, roll-in shortening, tempering fat, cocoa butter replacement, as a lubricant, or as a feedstock for various chemical processes. The fatty acid profile can be enriched in midchain profiles or the oil can be enriched in triglycerides of the saturated-unsaturated-saturated type. | 12-19-2013 |
20140178950 | GENETICALLY ENGINEERED MICROBIAL STRAINS INCLUDING CHLORELLA PROTOTHECOIDES LIPID PATHWAY GENES - Genetically engineered microbial, e.g., | 06-26-2014 |
20140377847 | Tailored Oils - Recombinant DNA techniques are used to produce oleaginous recombinant cells that produce triglyceride oils having desired fatty acid profiles and regiospecific or stereospecific profiles. Genes manipulated include those encoding stearoyl-ACP desturase, delta 12 fatty acid desaturase, acyl-ACP thioesterase, ketoacyl-ACP synthase, and lysophosphatidic acid acyltransferase. The oil produced can have enhanced oxidative or thermal stability, or can be useful as a frying oil, shortening, roll-in shortening, tempering fat, cocoa butter replacement, as a lubricant, or as a feedstock for various chemical processes. The fatty acid profile can be enriched in midchain profiles or the oil can be enriched in triglycerides of the saturated-unsaturated-saturated type. | 12-25-2014 |
20150125914 | TAILORED OILS - Recombinant DNA techniques are used to produce oleaginous recombinant cells that produce triglyceride oils having desired fatty acid profiles and regiospecific or stereospecific profiles. Genes manipulated include those encoding stearoyl-ACP desaturase, delta 12 fatty acid desaturase, acyl-ACP thioesterase, ketoacyl-ACP synthase, and lysophosphatidic acid acyltransferase. The oil produced can have enhanced oxidative or thermal stability, or can be useful as a frying oil, shortening, roll-in shortening, tempering fat, cocoa butter replacement, as a lubricant, or as a feedstock for various chemical processes. The fatty acid profile can be enriched in midchain profiles or the oil can be enriched in triglycerides of the saturated-unsaturated-saturated type. | 05-07-2015 |
Patent application number | Description | Published |
20080293736 | Compositions, Synthesis, and Methods of Using Quinolinone Based Atypical Antipsychotic Agents - The present invention provides novel quinolinone derivatives which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, and depression. | 11-27-2008 |
20110263704 | Methods of Using Cycloalkylmethylamines - The present invention provides novel cycloalkylmethylamine analogs, and methods of preparing cycloalkylmethylamine analogs. The present invention also provides methods of using cycloalkylmethylamine analogs and compositions of cycloalkylmethylamine analogs. The pharmaceutical compositions of the compounds of the present invention can be advantageously used for treating and/or preventing obesity and obesity related co-morbid indications. | 10-27-2011 |
20110263877 | Cycloalkylmethylamines - The present invention provides novel cycloalkylmethylamine analogs, and methods of preparing cycloalkylmethylamine analogs. The present invention also provides methods of using cycloalkylmethylamine analogs and compositions of cycloalkylmethylamine analogs. The pharmaceutical compositions of the compounds of the present invention can be advantageously used for treating and/or preventing obesity and obesity related co-morbid indications. | 10-27-2011 |
20110263888 | Cycloalkylmethylamines - The present invention provides novel cycloalkylmethylamine analogs, and methods of preparing cycloalkylmethylamine analogs. The present invention also provides methods of using cycloalkylmethylamine analogs and compositions of cycloalkylmethylamine analogs. The pharmaceutical compositions of the compounds of the present invention can be advantageously used for treating and/or preventing obesity and obesity related co-morbid indications. | 10-27-2011 |
20130231386 | SYNTHESIS, METHODS OF USING, AND COMPOSITIONS OF CYCLOALKYLMETHYLAMINES - The present invention provides novel cycloalkylmethylamine analogs, and methods of preparing cycloalkylmethylamine analogs. The present invention also provides methods of using cycloalkylmethylamine analogs and compositions of cycloalkylmethylamine analogs. The pharmaceutical compositions of the compounds of the present invention can be advantageously used for treating and/or preventing obesity and obesity related co-morbid indications. | 09-05-2013 |
20140024679 | COMPOSITIONS, SYNTHESIS, AND METHODS OF USING PHENYLCYCLOALKYLMETHYLAMINE DERIVATIVES - The present invention provides novel phenylcycloalkylmethylamine derivatives, and methods of preparing phenylcycloalkylmethylamine derivatives. The present invention also provides methods of using phenylcycloalkylmethylamine derivatives and compositions of phenylcycloalkylmethylamine derivatives. The pharmaceutical compositions of the compounds of the present invention can be used for treating and/or preventing obesity and obesity related co-morbid indications and depression and depression related co-morbid indications. | 01-23-2014 |
20140194508 | SYNTHESIS, METHODS OF USING, AND COMPOSITIONS OF CYCLOALKYLMETHYLAMINES - The present invention provides novel cycloalkylmethylamine analogs, and methods of preparing cycloalkylmethylamine analogs. The present invention also provides methods of using cycloalkylmethylamine analogs and compositions of cycloalkylmethylamine analogs. The pharmaceutical compositions of the compounds of the present invention can be advantageously used for treating and/or preventing obesity and obesity related co-morbid indications. | 07-10-2014 |
20160115121 | COMPOSITIONS, SYNTHESIS, AND METHODS OF USING PHENYLCYCLOALKYLMETHYLAMINE DERIVATIVES - The present invention provides novel phenylcycloalkylmethylamine derivatives, and methods of preparing phenylcycloalkylmethylamine derivatives. The present invention also provides methods of using phenylcycloalkylmethylamine derivatives and compositions of phenylcycloalkylmethylamine derivatives. The pharmaceutical compositions of the compounds of the present invention can be used for treating and/or preventing obesity and obesity related co-morbid indications and depression and depression related co-morbid indications. | 04-28-2016 |
Patent application number | Description | Published |
20130086657 | RELYING PARTY PLATFORM - A framework is provided for integrating Internet identities in enterprise identity and access management (IAM) infrastructures. A framework is provided for open authorization. A framework is also provided for relying party functionality. | 04-04-2013 |
20130086669 | MOBILE APPLICATION, SINGLE SIGN-ON MANAGEMENT - Techniques for managing single sign-on are provided. in some examples, single sign-on functionality may be provided for use on mobile devices by utilizing mobile applications, cloud applications, and/or other web-based applications. For example, a mobile application or mobile web browser may request to authenticate with or access one or more service providers. Authentication credentials may be requested from a user of the mobile device to facilitate such authentication and/or access. Based at least in part on a successful log-in, access to server resources from other applications on the same mobile device may be provided without successive or repetitive credential requests to the user. | 04-04-2013 |
20150089570 | CONFIGURABLE ADAPTIVE ACCESS MANAGER CALLOUTS - A framework, which conforms to the OAuth standard, involves a generic OAuth authorization server that can be used by multiple resource servers in order to ensure that access to resources stored on those resource servers is limited to access to which the resource owner consents. Each resource server registers, with the OAuth authorization server, metadata for that resource server, indicating scopes that are recognized by the resource server. The OAuth authorization server refers to this metadata when requesting consent from a resource owner on behalf of a client application, so that the consent will be of an appropriate scope. The OAuth authorization server refers to this metadata when constructing an access token to provide to the client application for use in accessing the resources on the resource server. The OAuth authorization server uses this metadata to map issued access tokens to the scopes to which those access tokens grant access. | 03-26-2015 |
20150089571 | PLUGGABLE AUTHORIZATION POLICIES - A framework, which conforms to the OAuth standard, involves a generic OAuth authorization server that can be used by multiple resource servers in order to ensure that access to resources stored on those resource servers is limited to access to which the resource owner consents. Each resource server registers, with the OAuth authorization server, metadata for that resource server, indicating scopes that are recognized by the resource server. The OAuth authorization server refers to this metadata when requesting consent from a resource owner on behalf of a client application, so that the consent will be of an appropriate scope. The OAuth authorization server refers to this metadata when constructing an access token to provide to the client application for use in accessing the resources on the resource server. The OAuth authorization server uses this metadata to map issued access tokens to the scopes to which those access tokens grant access. | 03-26-2015 |
20150089617 | SINGLE SIGN-ON (SSO) FOR MOBILE APPLICATIONS - A framework, which conforms to the OAuth standard, involves a generic OAuth authorization server that can be used by multiple resource servers in order to ensure that access to resources stored on those resource servers is limited to access to which the resource owner consents. Each resource server registers, with the OAuth authorization server, metadata for that resource server, indicating scopes that are recognized by the resource server. The OAuth authorization server refers to this metadata when requesting consent from a resource owner on behalf of a client application, so that the consent will be of an appropriate scope. The OAuth authorization server refers to this metadata when constructing an access token to provide to the client application for use in accessing the resources on the resource server. The OAuth authorization server uses this metadata to map issued access tokens to the scopes to which those access tokens grant access. | 03-26-2015 |
20150089622 | MOBILE OAUTH SERVICE - A framework, which conforms to the OAuth standard, involves a generic OAuth authorization server that can be used by multiple resource servers in order to ensure that access to resources stored on those resource servers is limited to access to which the resource owner consents. Each resource server registers, with the OAuth authorization server, metadata for that resource server, indicating scopes that are recognized by the resource server. The OAuth authorization server refers to this metadata when requesting consent from a resource owner on behalf of a client application, so that the consent will be of an appropriate scope. The OAuth authorization server refers to this metadata when constructing an access token to provide to the client application for use in accessing the resources on the resource server. The OAuth authorization server uses this metadata to map issued access tokens to the scopes to which those access tokens grant access. | 03-26-2015 |
20160080361 | SINGLE SIGN-ON (SSO) FOR MOBILE APPLICATIONS - A framework, which conforms to the OAuth standard, involves a generic OAuth authorization server that can be used by multiple resource servers in order to ensure that access to resources stored on those resource servers is limited to access to which the resource owner consents. Each resource server registers, with the OAuth authorization server, metadata for that resource server, indicating scopes that are recognized by the resource server. The OAuth authorization server refers to this metadata when requesting consent from a resource owner on behalf of a client application, so that the consent will be of an appropriate scope. The OAuth authorization server refers to this metadata when constructing an access token to provide to the client application for use in accessing the resources on the resource server. The OAuth authorization server uses this metadata to map issued access tokens to the scopes to which those access tokens grant access. | 03-17-2016 |
Patent application number | Description | Published |
20120315534 | Materials for Battery Electrolytes and Methods for Use - Described herein are materials for use in electrolytes that provide a number of desirable characteristics when implemented within batteries, such as high stability during battery cycling up to high temperatures high voltages, high discharge capacity, high coulombic efficiency, and excellent retention of discharge capacity and coulombic efficiency over several cycles of charging and discharging. In some embodiments, a high voltage electrolyte includes a base electrolyte and a set of additive compounds, which impart these desirable performance characteristics. | 12-13-2012 |
20120315536 | Materials for Battery Electrolytes and Methods for Use - Described herein are materials for use in electrolytes that provide a number of desirable characteristics when implemented within batteries, such as high stability during battery cycling up to high temperatures high voltages, high discharge capacity, high coulombic efficiency, and excellent retention of discharge capacity and coulombic efficiency over several cycles of charging and discharging. In some embodiments, a high voltage electrolyte includes a base electrolyte and a set of additive compounds, which impart these desirable performance characteristics. | 12-13-2012 |
20130029217 | Materials for Battery Electrolytes and Methods for Use - Described herein are materials for use in electrolytes that provide a number of desirable characteristics when implemented within batteries, such as high stability during battery cycling up to high temperatures high voltages, high discharge capacity, high coulombic efficiency, and excellent retention of discharge capacity and coulombic efficiency over several cycles of charging and discharging. In some embodiments, a high voltage electrolyte includes a base electrolyte and a set of additive compounds, which impart these desirable performance characteristics. | 01-31-2013 |
20140113186 | Materials for Battery Electrolytes and Methods for Use - Described herein are materials for use in electrolytes that provide a number of desirable characteristics when implemented within batteries, such as high stability during battery cycling up to high temperatures high voltages, high discharge capacity, high coulombic efficiency, and excellent retention of discharge capacity and coulombic efficiency over several cycles of charging and discharging. In some embodiments, a high voltage electrolyte includes a base electrolyte and a set of additive compounds, which impart these desirable performance characteristics. | 04-24-2014 |
20140152269 | Materials for Battery Electrolytes and Methods for Use - Described herein are materials for use in electrolytes that provide a number of desirable characteristics when implemented within batteries, such as high stability during battery cycling up to high temperatures high voltages, high discharge capacity, high coulombic efficiency, and excellent retention of discharge capacity and coulombic efficiency over several cycles of charging and discharging. In some embodiments, a high voltage electrolyte includes a base electrolyte and a set of additive compounds, which impart these desirable performance characteristics. | 06-05-2014 |
Patent application number | Description | Published |
20100168843 | Coating For Implantable Devices And A Method Of Forming The Same - Coatings for implantable devices or endoluminal prosthesis, such as stents, are provided, including a method of forming the coatings. The coatings can be used for the delivery of an active ingredient or a combination of active ingredients. | 07-01-2010 |
20100198339 | Coating for Implantable Devices and a Method of Forming the Same - Coatings for implantable devices or endoluminal prosthesis, such as stents, are provided, including a method of forming the coatings. The coatings can be used for the delivery of an active ingredient or a combination of active ingredients. | 08-05-2010 |
20100198340 | Coating for Implantable Devices and a Method of Forming the Same - Coatings for implantable devices or endoluminal prosthesis, such as stents, are provided, including a method of forming the coatings. The coatings can be used for the delivery of an active ingredient or a combination of active ingredients. | 08-05-2010 |
20100198341 | COATING FOR IMPLANTABLE DEVICES AND A METHOD OF FORMING THE SAME - Coatings for implantable devices or endoluminal prosthesis, such as stents, are provided, including a method of forming the coatings. The coatings can be used for the delivery of an active ingredient or a combination of active ingredients. | 08-05-2010 |
20100198342 | COATING FOR IMPLANTABLE DEVICES AND A METHOD OF FORMING THE SAME - Coatings for implantable devices or endoluminal prosthesis, such as stents, are provided, including a method of forming the coatings. The coatings can be used for the delivery of an active ingredient or a combination of active ingredients. | 08-05-2010 |
20100198343 | COATING FOR IMPLANTABLE DEVICES AND A METHOD OF FORMING THE SAME - Coatings for implantable devices or endoluminal prosthesis, such as stents, are provided, including a method of forming the coatings. The coatings can be used for the delivery of an active ingredient or a combination of active ingredients. | 08-05-2010 |
20110070283 | Coating For Implantable Devices And A Method Of Forming The Same - Coatings for implantable devices or endoluminal prosthesis, such as stents, are provided, including a method of forming the coatings. The coatings can be used for the delivery of an active ingredient or a combination of active ingredients. | 03-24-2011 |
20120185034 | Coating For Implantable Devices And A Method Of Forming The Same - Coatings for implantable devices or endoluminal prosthesis, such as stents, are provided, including a method of forming the coatings. The coatings can serve as a primer coating for subsequent coatings that can be used for the delivery of an active ingredient or a combination of active ingredients. | 07-19-2012 |
Patent application number | Description | Published |
20120071962 | INTRAVASCULAR STENT - Stents are provided with scaffold structures which have low exposures when implanted in arteries and other blood vessels and lumens. The cross-sectional dimensions, materials, and patterns are controlled to provide sufficient strength and coverage while maintaining the low exposure. | 03-22-2012 |
20120187606 | BIODEGRADABLE ENDOPROSTHESES AND METHODS FOR THEIR FABRICATION - Biodegradable endoprostheses are formed from amorphous polymers having desirable biodegradation characteristics. The strength of such amorphous polymers is enhanced by annealing to increase crystallinity without substantially increasing the biodegradation time. | 07-26-2012 |
20120226345 | BIODEGRADABLE ENDOPROSTHESES AND METHODS FOR THEIR FABRICATION - Biodegradable endoprostheses are formed from amorphous polymers having desirable biodegradation characteristics. The strength of such amorphous polymers is enhanced by annealing to increase crystallinity without substantially increasing the biodegradation time. | 09-06-2012 |
20120271396 | BIODEGRADABLE ENDOPROSTHESES AND METHODS FOR THEIR FABRICATION - The disclosure provides biodegradable implantable devices such as a stent comprising a biodegradable polymeric wherein the polymeric material is treated to control crystallinity and/or Tg. The stent is capable to expand at body temperature from a crimped configuration to a deployed diameter and have sufficient strength to support a body lumen. | 10-25-2012 |
20130150943 | BIODEGRADABLE ENDOPROSTHESES AND METHODS FOR THEIR FABRICATION - The disclosure provides biodegradable implantable devices such as a stent comprising a biodegradable polymeric wherein the polymeric material is treated to control crystallinity and/or Tg. The stent is capable to expand at body temperature from a crimped configuration to a deployed diameter and have sufficient strength to support a body lumen. | 06-13-2013 |
20130230571 | MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE - The present disclosure provides a device for intracorporeal use which comprises an implant or a temporary device and at least one source of myolimus or a derivative thereof. The present disclosure also provides a method of inhibiting cell proliferation, inflammation or cytokine production by systemic or local administration of a therapeutically effective amount of myolimus or a derivative thereof. Further included in the present disclosure is a method of treating an ophthalmic condition or disease by administering a therapeutically effective amount of myolimus or a derivative thereof. | 09-05-2013 |
20130331927 | BIODEGRADABLE ENDOPROSTHESIS AND METHODS FOR THEIR FABRICATION - The disclosure provides biodegradable implantable devices such as a stent comprising a biodegradable polymeric wherein the polymeric material is treated to control crystallinity and/or Tg. The stent is capable to expand at body temperature in a body lumen from a crimped configuration to a deployed diameter and have sufficient strength to support a body lumen. | 12-12-2013 |
20140188243 | BIODEGRADABLE ENDOPROSTHESES AND METHODS FOR THEIR FABRICATION - The disclosure provides biodegradable implantable devices such as a stent comprising a biodegradable polymeric wherein the polymeric material is treated to control crystallinity and/or Tg. The stent is capable to expand at body temperature from a crimped configuration to a deployed diameter and have sufficient strength to support a body lumen. | 07-03-2014 |
20140350659 | BIODEGRADABLE ENDOPROSTHESES AND METHODS FOR THEIR FABRICATION - Biodegradable endoprostheses are formed from amorphous polymers having desirable biodegradation characteristics. The strength of such amorphous polymers is enhanced by annealing to increase crystallinity without substantially increasing the biodegradation time. | 11-27-2014 |
20150025619 | BIODEGRADABLE ENDOPROSTHESES AND METHODS FOR THEIR FABRICATION - The disclosure provides biodegradable implantable devices such as a stent comprising a biodegradable polymeric wherein the polymeric material is treated to control crystallinity and/or Tg. The stent is capable to expand at body temperature in a body lumen from a crimped configuration to a deployed diameter and have sufficient strength to support a body lumen. | 01-22-2015 |
20150320577 | BIODEGRADABLE ENDOPROSTHESES AND METHODS FOR THEIR FABRICATION - The disclosure provides biodegradable implantable devices such as a stent comprising a biodegradable polymeric wherein the polymeric material is treated to control crystallinity and/or Tg. The stent is capable to expand at body temperature in a body lumen from a crimped configuration to a deployed diameter and have sufficient strength to support a body lumen. | 11-12-2015 |
20150374521 | BIODEGRADABLE ENDOPROSTHESES AND METHODS FOR THEIR FABRICATION - The disclosure provides biodegradable implantable devices such as a stent comprising a biodegradable polymeric wherein the polymeric material is treated to control crystallinity and/or Tg. The stent is capable to expand at body temperature from a crimped configuration to a deployed diameter and have sufficient strength to support a body lumen. | 12-31-2015 |
20160045342 | BIODEGRADABLE ENDOPROSTHESES AND METHODS OF THEIR FABRICATION - A biodegradable stent prosthesis formed from a degradable polymeric material, having a plurality of luminal, abluminal, and side surfaces, where at least some of the abluminal surfaces are concave and optionally the side surfaces are convex. | 02-18-2016 |
20160045343 | BIODEGRADABLE ENDOPROSTHESES AND METHODS OF THEIR FABRICATION - A biodegradable stent prosthesis formed from a degradable material, having a plurality of luminal, abluminal, and side surface regions, wherein a surface portion extending between the abluminal and luminal surface region of at least some structural elements is convex or bulbous and optionally, where at least some of the abluminal surface regions may be concave. | 02-18-2016 |
20160045344 | BIODEGRADABLE ENDOPROSTHESES AND METHODS OF THEIR FABRICATION - A biodegradable stent prosthesis formed from a degradable material, having a plurality of luminal, abluminal, and side surface regions, wherein a surface portion extending between the abluminal and luminal surface region of at least some structural elements is convex. | 02-18-2016 |
20160045345 | INTRAVASCULAR STENT - Stents are provided with scaffold structures which have low exposures when implanted in arteries and other blood vessels and lumens. The cross-sectional dimensions, materials, and patterns are controlled to provide sufficient strength and coverage while maintaining the low exposure. | 02-18-2016 |
20160067389 | BIODEGRADABLE ENDOPROSTHESES AND METHODS FOR THEIR FABRICATION - Biodegradable endoprostheses are formed from amorphous polymers having desirable biodegradation characteristics. The strength of such amorphous polymers is enhanced by annealing to increase crystallinity without substantially increasing the biodegradation time. | 03-10-2016 |
20160128849 | Degradable implantable medical devices - Devices and methods are provided for an implantable medical device which is degradable over a clinically relevant period of time. The medical devices may have the form of implants, graft implants, vascular implants, non vascular implants, wound closure implants, sutures, drug delivery implants, biologic delivery implants, urinary tract implants, inter-uterine implants, organ implants, bone implants including bone plates, bone screws, dental implants, spinal disks, or the like. In preferred embodiments, the implantable medical device comprises an implantable luminal prosthesis, such as vascular and non-vascular stents and stents grafts. | 05-12-2016 |
Patent application number | Description | Published |
20120315551 | Materials for Battery Electrolytes and Methods for Use - Described herein are materials for use in electrolytes that provide a number of desirable characteristics when implemented within batteries, such as high stability during battery cycling up to high temperatures high voltages, high discharge capacity, high coulombic efficiency, and excellent retention of discharge capacity and coulombic efficiency over several cycles of charging and discharging. In some embodiments, a high voltage electrolyte includes a base electrolyte and a set of additive compounds, which impart these desirable performance characteristics. | 12-13-2012 |
20120328939 | Materials for Battery Electrolytes and Methods for Use - Described herein are materials for use in electrolytes that provide a number of desirable characteristics when implemented within batteries, such as high stability during battery cycling up to high temperatures high voltages, high discharge capacity, high coulombic efficiency, and excellent retention of discharge capacity and coulombic efficiency over several cycles of charging and discharging. In some embodiments, a high voltage electrolyte includes a base electrolyte and a set of additive compounds, which impart these desirable performance characteristics. | 12-27-2012 |
20130059200 | Materials for Battery Electrolytes and Methods for Use - Described herein are materials for use in electrolytes that provide a number of desirable characteristics when implemented within batteries, such as high stability during battery cycling up to high temperatures high voltages, high discharge capacity, high coulombic efficiency, and excellent retention of discharge capacity and coulombic efficiency over several cycles of charging and discharging. In some embodiments, a high voltage electrolyte includes a base electrolyte and a set of additive compounds, which impart these desirable performance characteristics. | 03-07-2013 |
20140120414 | Materials for Battery Electrolytes and Methods for Use - Described herein are materials for use in electrolytes that provide a number of desirable characteristics when implemented within batteries, such as high stability during battery cycling up to high temperatures high voltages, high discharge capacity, high coulombic efficiency, and excellent retention of discharge capacity and coulombic efficiency over several cycles of charging and discharging. In some embodiments, a high voltage electrolyte includes a base electrolyte and a set of additive compounds, which impart these desirable performance characteristics. | 05-01-2014 |
20140295219 | Materials for Battery Electrolytes and Methods for Use - Described herein are materials for use in electrolytes that provide a number of desirable characteristics when implemented within batteries, such as high stability during battery cycling up to high temperatures high voltages, high discharge capacity, high coulombic efficiency, and excellent retention of discharge capacity and coulombic efficiency over several cycles of charging and discharging. In some embodiments, a high voltage electrolyte includes a base electrolyte and a set of additive compounds, which impart these desirable performance characteristics. | 10-02-2014 |